| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | HSPG2 THBS3 FBN2 PXDN COMP LAMA5 LAMB1 PAPLN LAMC2 SSPOP FBN3 | 8.81e-12 | 188 | 60 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | HSPG2 THBS3 FBN2 COMP MEGF6 MEGF8 ITGB1BP2 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 4.12e-11 | 749 | 60 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 8.80e-10 | 16 | 60 | 5 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 4.05e-09 | 21 | 60 | 5 | GO:0030228 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 5.64e-06 | 85 | 60 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | structural molecule activity | HSPG2 THBS3 FBN2 PXDN COMP JAG1 LAMA5 LAMB1 PAPLN LAMC2 SSPOP FBN3 | 1.12e-05 | 891 | 60 | 12 | GO:0005198 |
| GeneOntologyMolecularFunction | integrin binding | 1.41e-05 | 175 | 60 | 6 | GO:0005178 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 1.51e-04 | 268 | 60 | 6 | GO:0005539 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.24e-03 | 156 | 60 | 4 | GO:0019838 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle binding | 1.32e-03 | 18 | 60 | 2 | GO:0030169 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.38e-03 | 73 | 60 | 3 | GO:0050840 | |
| GeneOntologyMolecularFunction | collagen binding | 1.86e-03 | 81 | 60 | 3 | GO:0005518 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 2.06e-03 | 599 | 60 | 7 | GO:0050839 | |
| GeneOntologyMolecularFunction | heparin binding | 2.65e-03 | 192 | 60 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 2.83e-03 | 323 | 60 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | Notch binding | 2.97e-03 | 27 | 60 | 2 | GO:0005112 | |
| GeneOntologyMolecularFunction | amyloid-beta binding | 3.59e-03 | 102 | 60 | 3 | GO:0001540 | |
| GeneOntologyBiologicalProcess | axon guidance | SEMA4D HSPG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 8.89e-09 | 285 | 60 | 10 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | SEMA4D HSPG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 9.19e-09 | 286 | 60 | 10 | GO:0097485 |
| GeneOntologyBiologicalProcess | artery development | 1.15e-07 | 133 | 60 | 7 | GO:0060840 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 2.75e-07 | 92 | 60 | 6 | GO:0048844 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 3.03e-07 | 20 | 60 | 4 | GO:0003184 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 THBS3 NTNG2 HOXC8 FBN2 COMP MEGF8 JAG1 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 AR NOTCH1 NOTCH2 | 4.36e-07 | 1269 | 60 | 16 | GO:0009887 |
| GeneOntologyBiologicalProcess | tube morphogenesis | HSPG2 PXDN COMP MEGF8 JAG1 LRP2 LAMA5 ESM1 ROBO1 LDLR AR ST14 NOTCH1 NOTCH2 STAB1 | 5.37e-07 | 1125 | 60 | 15 | GO:0035239 |
| GeneOntologyBiologicalProcess | axonogenesis | SEMA4D HSPG2 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 6.11e-07 | 566 | 60 | 11 | GO:0007409 |
| GeneOntologyBiologicalProcess | pulmonary valve development | 6.58e-07 | 24 | 60 | 4 | GO:0003177 | |
| GeneOntologyBiologicalProcess | axon development | SEMA4D HSPG2 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 2.09e-06 | 642 | 60 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | vasculature development | HSPG2 PXDN COMP MEGF8 JAG1 LRP2 ESM1 ROBO1 LDLR SVEP1 NOTCH1 NOTCH2 STAB1 | 3.31e-06 | 969 | 60 | 13 | GO:0001944 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | HSPG2 PXDN COMP MEGF8 JAG1 LRP2 ESM1 ROBO1 LDLR NOTCH1 NOTCH2 STAB1 | 3.34e-06 | 817 | 60 | 12 | GO:0048514 |
| GeneOntologyBiologicalProcess | aorta development | 3.57e-06 | 80 | 60 | 5 | GO:0035904 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 6.05e-06 | 89 | 60 | 5 | GO:0060411 | |
| GeneOntologyBiologicalProcess | tube development | HSPG2 PXDN COMP MEGF8 JAG1 LRP2 LAMA5 ESM1 ROBO1 LDLR AR ST14 NOTCH1 NOTCH2 STAB1 | 8.20e-06 | 1402 | 60 | 15 | GO:0035295 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | SEMA4D HSPG2 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 8.97e-06 | 748 | 60 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | skeletal system development | SEMA4D HSPG2 THBS3 HOXC8 FBN2 COMP MEGF8 WFIKKN1 LAMA5 NOTCH2 | 1.02e-05 | 615 | 60 | 10 | GO:0001501 |
| GeneOntologyBiologicalProcess | blood vessel development | HSPG2 PXDN COMP MEGF8 JAG1 LRP2 ESM1 ROBO1 LDLR NOTCH1 NOTCH2 STAB1 | 1.23e-05 | 929 | 60 | 12 | GO:0001568 |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.29e-05 | 377 | 60 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.32e-05 | 378 | 60 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.34e-05 | 379 | 60 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.35e-05 | 50 | 60 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | skeletal system morphogenesis | 1.54e-05 | 277 | 60 | 7 | GO:0048705 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | SEMA4D HSPG2 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 1.72e-05 | 802 | 60 | 11 | GO:0048812 |
| GeneOntologyBiologicalProcess | bone trabecula morphogenesis | 1.85e-05 | 18 | 60 | 3 | GO:0061430 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | SEMA4D HSPG2 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 2.09e-05 | 819 | 60 | 11 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | SEMA4D HSPG2 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 2.26e-05 | 826 | 60 | 11 | GO:0048858 |
| GeneOntologyBiologicalProcess | trabecula morphogenesis | 2.28e-05 | 57 | 60 | 4 | GO:0061383 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 2.29e-05 | 197 | 60 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 2.44e-05 | 58 | 60 | 4 | GO:0003197 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 2.49e-05 | 3 | 60 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | epithelial tube morphogenesis | 2.85e-05 | 421 | 60 | 8 | GO:0060562 | |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ERBB3 FBN2 COMP MEGF8 WFIKKN1 LRP2 KCP ESM1 ROBO1 AR SVEP1 NOTCH1 NOTCH2 | 2.89e-05 | 1186 | 60 | 13 | GO:0007167 |
| GeneOntologyBiologicalProcess | cell morphogenesis | SEMA4D HSPG2 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 AR ST14 NOTCH1 NOTCH2 | 3.10e-05 | 1194 | 60 | 13 | GO:0000902 |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 3.39e-05 | 63 | 60 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | response to BMP | 3.75e-05 | 215 | 60 | 6 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 3.75e-05 | 215 | 60 | 6 | GO:0071773 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | 4.22e-05 | 445 | 60 | 8 | GO:0141091 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 4.40e-05 | 134 | 60 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | circulatory system development | HSPG2 ERBB3 PXDN COMP MEGF8 JAG1 LRP2 ESM1 ROBO1 LDLR SVEP1 NOTCH1 NOTCH2 STAB1 | 5.14e-05 | 1442 | 60 | 14 | GO:0072359 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 6.39e-05 | 74 | 60 | 4 | GO:0002011 | |
| GeneOntologyBiologicalProcess | regionalization | 6.98e-05 | 478 | 60 | 8 | GO:0003002 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 7.03e-05 | 619 | 60 | 9 | GO:0002009 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | 7.39e-05 | 482 | 60 | 8 | GO:0007178 | |
| GeneOntologyBiologicalProcess | heart valve development | 7.86e-05 | 78 | 60 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | animal organ formation | 7.86e-05 | 78 | 60 | 4 | GO:0048645 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 8.27e-05 | 5 | 60 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | coronary vasculature development | 1.00e-04 | 83 | 60 | 4 | GO:0060976 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion | 1.05e-04 | 375 | 60 | 7 | GO:0007162 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 1.05e-04 | 161 | 60 | 5 | GO:0003206 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation | 1.15e-04 | 514 | 60 | 8 | GO:0050678 | |
| GeneOntologyBiologicalProcess | bone development | 1.17e-04 | 264 | 60 | 6 | GO:0060348 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 1.24e-04 | 6 | 60 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | positive regulation of viral transcription | 1.24e-04 | 6 | 60 | 2 | GO:0050434 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 1.24e-04 | 6 | 60 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 1.24e-04 | 6 | 60 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.35e-04 | 526 | 60 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | positive regulation of small GTPase mediated signal transduction | 1.49e-04 | 92 | 60 | 4 | GO:0051057 | |
| GeneOntologyBiologicalProcess | heart formation | 1.56e-04 | 36 | 60 | 3 | GO:0060914 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 1.62e-04 | 94 | 60 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | muscle structure development | ERBB3 COMP WFIKKN1 ITGB1BP2 JAG1 LRP2 LAMA5 LAMB1 NOTCH1 NOTCH2 | 1.68e-04 | 858 | 60 | 10 | GO:0061061 |
| GeneOntologyBiologicalProcess | gland morphogenesis | 1.68e-04 | 178 | 60 | 5 | GO:0022612 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 1.73e-04 | 7 | 60 | 2 | GO:1904352 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 1.87e-04 | 412 | 60 | 7 | GO:0090287 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 1.99e-04 | 39 | 60 | 3 | GO:0003180 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 2.04e-04 | 418 | 60 | 7 | GO:0051962 | |
| GeneOntologyBiologicalProcess | embryonic morphogenesis | 2.04e-04 | 713 | 60 | 9 | GO:0048598 | |
| GeneOntologyBiologicalProcess | specification of animal organ identity | 2.31e-04 | 41 | 60 | 3 | GO:0010092 | |
| GeneOntologyBiologicalProcess | positive regulation of BMP signaling pathway | 2.48e-04 | 42 | 60 | 3 | GO:0030513 | |
| GeneOntologyBiologicalProcess | anatomical structure formation involved in morphogenesis | HSPG2 THBS3 FBN2 PXDN JAG1 LRP2 ESM1 ROBO1 AR ST14 NOTCH1 NOTCH2 STAB1 | 2.77e-04 | 1483 | 60 | 13 | GO:0048646 |
| GeneOntologyBiologicalProcess | neuron projection development | SEMA4D HSPG2 LRP12 NTNG2 MEGF8 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 NOTCH1 NOTCH2 | 2.79e-04 | 1285 | 60 | 12 | GO:0031175 |
| GeneOntologyBiologicalProcess | atrioventricular node development | 2.96e-04 | 9 | 60 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 2.96e-04 | 9 | 60 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 2.97e-04 | 110 | 60 | 4 | GO:0072080 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 2.97e-04 | 750 | 60 | 9 | GO:0048729 | |
| GeneOntologyBiologicalProcess | aortic valve development | 3.25e-04 | 46 | 60 | 3 | GO:0003176 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 3.35e-04 | 321 | 60 | 6 | GO:0003007 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation | 3.42e-04 | 603 | 60 | 8 | GO:0050673 | |
| GeneOntologyBiologicalProcess | cartilage development involved in endochondral bone morphogenesis | 3.46e-04 | 47 | 60 | 3 | GO:0060351 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 3.46e-04 | 47 | 60 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | renal tubule development | 3.63e-04 | 116 | 60 | 4 | GO:0061326 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 3.69e-04 | 10 | 60 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 3.69e-04 | 10 | 60 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 3.69e-04 | 10 | 60 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | distal tubule development | 3.69e-04 | 10 | 60 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 3.78e-04 | 212 | 60 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | 4.07e-04 | 333 | 60 | 6 | GO:0051056 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 4.34e-04 | 625 | 60 | 8 | GO:0051960 | |
| GeneOntologyBiologicalProcess | regulation of epithelial cell proliferation involved in prostate gland development | 4.50e-04 | 11 | 60 | 2 | GO:0060768 | |
| GeneOntologyBiologicalProcess | bone morphogenesis | 4.68e-04 | 124 | 60 | 4 | GO:0060349 | |
| GeneOntologyBiologicalProcess | limb development | 4.85e-04 | 224 | 60 | 5 | GO:0060173 | |
| GeneOntologyBiologicalProcess | appendage development | 4.85e-04 | 224 | 60 | 5 | GO:0048736 | |
| GeneOntologyBiologicalProcess | positive regulation of Notch signaling pathway | 4.94e-04 | 53 | 60 | 3 | GO:0045747 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 5.06e-04 | 347 | 60 | 6 | GO:0090092 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 5.27e-04 | 128 | 60 | 4 | GO:0072009 | |
| GeneOntologyBiologicalProcess | regulation of lysosomal protein catabolic process | 5.39e-04 | 12 | 60 | 2 | GO:1905165 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 5.39e-04 | 12 | 60 | 2 | GO:0070831 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in prostate gland development | 5.39e-04 | 12 | 60 | 2 | GO:0060767 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 5.62e-04 | 354 | 60 | 6 | GO:0050769 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 5.75e-04 | 131 | 60 | 4 | GO:0030510 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 THBS3 FBN2 PXDN ZAN COMP MEGF6 ADAMTSL5 LAMA5 LAMB1 PAPLN LAMC2 SSPOP FBN3 SVEP1 | 3.46e-10 | 656 | 60 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 THBS3 FBN2 PXDN ZAN COMP MEGF6 ADAMTSL5 LAMA5 LAMB1 PAPLN LAMC2 SSPOP FBN3 SVEP1 | 3.60e-10 | 658 | 60 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | HSPG2 THBS3 FBN2 PXDN COMP MEGF6 ADAMTSL5 LAMA5 LAMB1 PAPLN LAMC2 SSPOP | 2.88e-08 | 530 | 60 | 12 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | 1.35e-06 | 122 | 60 | 6 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin complex | 2.66e-06 | 10 | 60 | 3 | GO:0043256 | |
| GeneOntologyCellularComponent | microfibril | 6.30e-06 | 13 | 60 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | laminin-2 complex | 8.10e-06 | 2 | 60 | 2 | GO:0005607 | |
| GeneOntologyCellularComponent | laminin-10 complex | 2.43e-05 | 3 | 60 | 2 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-5 complex | 4.84e-05 | 4 | 60 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | receptor complex | 1.33e-03 | 581 | 60 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 1.58e-03 | 80 | 60 | 3 | GO:0005905 | |
| MousePheno | limbs/digits/tail phenotype | HSPG2 THBS3 HOXC8 FBN2 PXDN COMP MEGF8 WFIKKN1 AEBP2 LRP2 LAMA5 LAMB1 LAMC2 HPS5 ST14 SVEP1 NOTCH2 | 1.14e-06 | 1258 | 51 | 17 | MP:0005371 |
| MousePheno | abnormal ophthalmic nerve morphology | 7.79e-05 | 4 | 51 | 2 | MP:0009798 | |
| MousePheno | abnormal tail morphology | 9.56e-05 | 403 | 51 | 8 | MP:0002111 | |
| MousePheno | micrognathia | 1.08e-04 | 68 | 51 | 4 | MP:0002639 | |
| MousePheno | short snout | 1.33e-04 | 136 | 51 | 5 | MP:0000445 | |
| MousePheno | small snout | 1.74e-04 | 144 | 51 | 5 | MP:0030190 | |
| MousePheno | centrally nucleated skeletal muscle fibers | 2.03e-04 | 80 | 51 | 4 | MP:0009404 | |
| MousePheno | abnormal muscle electrophysiology | 2.11e-04 | 32 | 51 | 3 | MP:0004145 | |
| MousePheno | abnormal limb morphology | HSPG2 THBS3 HOXC8 FBN2 COMP MEGF8 WFIKKN1 LAMA5 LAMC2 ST14 SVEP1 NOTCH2 | 2.54e-04 | 1028 | 51 | 12 | MP:0002109 |
| MousePheno | abnormal ear morphology | 2.75e-04 | 470 | 51 | 8 | MP:0002102 | |
| MousePheno | microphthalmia | 3.20e-04 | 362 | 51 | 7 | MP:0001297 | |
| MousePheno | abnormal snout morphology | 3.28e-04 | 257 | 51 | 6 | MP:0000443 | |
| MousePheno | hearing/vestibular/ear phenotype | HSPG2 NTNG2 FBN2 PRRC2C JAG1 LRP2 LAMA5 LAMC2 HPS5 LDLR NOTCH1 | 3.42e-04 | 905 | 51 | 11 | MP:0005377 |
| MousePheno | decreased circulating unsaturated transferrin level | 3.60e-04 | 8 | 51 | 2 | MP:0011897 | |
| MousePheno | abnormal eye size | 3.96e-04 | 375 | 51 | 7 | MP:0002697 | |
| MousePheno | abnormal basement membrane morphology | 4.11e-04 | 40 | 51 | 3 | MP:0004272 | |
| Domain | Growth_fac_rcpt_ | HSPG2 ERBB3 THBS3 FBN2 COMP MEGF6 MEGF8 JAG1 LRP2 LAMA5 LAMB1 ESM1 LAMC2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 2.25e-29 | 156 | 59 | 21 | IPR009030 |
| Domain | EGF | HSPG2 THBS3 NTNG2 FBN2 ZAN COMP MEGF6 MEGF8 JAG1 LRP2 LAMA5 LAMB1 LAMC2 ADGRE5 NAGPA LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 3.43e-27 | 235 | 59 | 22 | SM00181 |
| Domain | EGF-like_dom | HSPG2 THBS3 NTNG2 FBN2 ZAN COMP MEGF6 MEGF8 JAG1 LRP2 LAMA5 LAMB1 LAMC2 ADGRE5 NAGPA LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 1.27e-26 | 249 | 59 | 22 | IPR000742 |
| Domain | EGF_1 | HSPG2 THBS3 NTNG2 FBN2 ZAN COMP MEGF6 MEGF8 JAG1 LRP2 LAMA5 LAMB1 LAMC2 NAGPA LRP1B SSPOP LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 2.16e-26 | 255 | 59 | 22 | PS00022 |
| Domain | EGF_2 | HSPG2 THBS3 NTNG2 FBN2 ZAN COMP MEGF6 MEGF8 JAG1 LRP2 LAMA5 LAMB1 LAMC2 NAGPA LRP1B SSPOP LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 5.13e-26 | 265 | 59 | 22 | PS01186 |
| Domain | EGF-like_CS | HSPG2 THBS3 NTNG2 FBN2 ZAN COMP MEGF6 MEGF8 JAG1 LRP2 LAMA5 LAMB1 LAMC2 NAGPA LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 1.62e-24 | 261 | 59 | 21 | IPR013032 |
| Domain | EGF_3 | HSPG2 THBS3 NTNG2 FBN2 ZAN COMP MEGF6 MEGF8 JAG1 LRP2 ADGRE5 NAGPA LRP1B SSPOP LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 7.90e-24 | 235 | 59 | 20 | PS50026 |
| Domain | EGF_CA | HSPG2 THBS3 FBN2 COMP MEGF6 MEGF8 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 3.45e-22 | 122 | 59 | 16 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | HSPG2 THBS3 FBN2 COMP MEGF6 MEGF8 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 4.53e-22 | 124 | 59 | 16 | IPR001881 |
| Domain | EGF_CA | THBS3 FBN2 COMP MEGF6 MEGF8 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 | 7.15e-21 | 86 | 59 | 14 | PF07645 |
| Domain | EGF_Ca-bd_CS | THBS3 FBN2 COMP MEGF6 MEGF8 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 | 4.30e-20 | 97 | 59 | 14 | IPR018097 |
| Domain | EGF_CA | THBS3 FBN2 COMP MEGF6 MEGF8 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 | 5.81e-20 | 99 | 59 | 14 | PS01187 |
| Domain | EGF | HSPG2 NTNG2 ZAN MEGF6 JAG1 LRP2 NAGPA LRP1B FBN3 SVEP1 NOTCH1 NOTCH2 STAB1 | 9.91e-17 | 126 | 59 | 13 | PF00008 |
| Domain | ASX_HYDROXYL | FBN2 MEGF6 MEGF8 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 | 2.56e-16 | 100 | 59 | 12 | PS00010 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FBN2 MEGF6 MEGF8 JAG1 LRP2 ADGRE5 LRP1B LDLR FBN3 SVEP1 NOTCH1 NOTCH2 | 5.28e-16 | 106 | 59 | 12 | IPR000152 |
| Domain | Laminin_EGF | 1.33e-13 | 35 | 59 | 8 | PF00053 | |
| Domain | EGF_Lam | 1.33e-13 | 35 | 59 | 8 | SM00180 | |
| Domain | EGF_extracell | 2.16e-13 | 60 | 59 | 9 | IPR013111 | |
| Domain | EGF_2 | 2.16e-13 | 60 | 59 | 9 | PF07974 | |
| Domain | Laminin_EGF | 2.75e-13 | 38 | 59 | 8 | IPR002049 | |
| Domain | hEGF | 2.44e-12 | 28 | 59 | 7 | PF12661 | |
| Domain | EGF_LAM_2 | 4.18e-12 | 30 | 59 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 4.18e-12 | 30 | 59 | 7 | PS01248 | |
| Domain | LDLR_class-A_CS | 3.73e-11 | 40 | 59 | 7 | IPR023415 | |
| Domain | Ldl_recept_a | 8.98e-11 | 45 | 59 | 7 | PF00057 | |
| Domain | - | 1.06e-10 | 46 | 59 | 7 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.45e-10 | 48 | 59 | 7 | PS01209 | |
| Domain | LDLRA_2 | 1.68e-10 | 49 | 59 | 7 | PS50068 | |
| Domain | LDrepeatLR_classA_rpt | 1.68e-10 | 49 | 59 | 7 | IPR002172 | |
| Domain | LDLa | 1.68e-10 | 49 | 59 | 7 | SM00192 | |
| Domain | TIL_dom | 8.78e-08 | 14 | 59 | 4 | IPR002919 | |
| Domain | VWC | 1.23e-07 | 38 | 59 | 5 | SM00214 | |
| Domain | VWF_dom | 2.06e-07 | 42 | 59 | 5 | IPR001007 | |
| Domain | VWC_out | 3.36e-07 | 19 | 59 | 4 | SM00215 | |
| Domain | cEGF | 1.27e-06 | 26 | 59 | 4 | IPR026823 | |
| Domain | cEGF | 1.27e-06 | 26 | 59 | 4 | PF12662 | |
| Domain | LAMININ_IVA | 1.66e-06 | 8 | 59 | 3 | PS51115 | |
| Domain | Laminin_B | 1.66e-06 | 8 | 59 | 3 | PF00052 | |
| Domain | LamB | 1.66e-06 | 8 | 59 | 3 | SM00281 | |
| Domain | Laminin_IV | 1.66e-06 | 8 | 59 | 3 | IPR000034 | |
| Domain | VWFC_1 | 4.91e-06 | 36 | 59 | 4 | PS01208 | |
| Domain | VWFC_2 | 6.12e-06 | 38 | 59 | 4 | PS50184 | |
| Domain | Unchr_dom_Cys-rich | 8.37e-06 | 13 | 59 | 3 | IPR014853 | |
| Domain | C8 | 8.37e-06 | 13 | 59 | 3 | SM00832 | |
| Domain | Ldl_recept_b | 1.06e-05 | 14 | 59 | 3 | PF00058 | |
| Domain | LDLRB | 1.06e-05 | 14 | 59 | 3 | PS51120 | |
| Domain | - | 1.23e-05 | 95 | 59 | 5 | 2.60.120.200 | |
| Domain | LY | 1.33e-05 | 15 | 59 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.33e-05 | 15 | 59 | 3 | IPR000033 | |
| Domain | VWD | 1.63e-05 | 16 | 59 | 3 | SM00216 | |
| Domain | VWF_type-D | 1.63e-05 | 16 | 59 | 3 | IPR001846 | |
| Domain | Laminin_N | 1.63e-05 | 16 | 59 | 3 | IPR008211 | |
| Domain | LAMININ_NTER | 1.63e-05 | 16 | 59 | 3 | PS51117 | |
| Domain | VWFD | 1.63e-05 | 16 | 59 | 3 | PS51233 | |
| Domain | Laminin_N | 1.63e-05 | 16 | 59 | 3 | PF00055 | |
| Domain | VWD | 1.63e-05 | 16 | 59 | 3 | PF00094 | |
| Domain | LamNT | 1.63e-05 | 16 | 59 | 3 | SM00136 | |
| Domain | Thbs/COMP_coiled-coil | 2.94e-05 | 3 | 59 | 2 | IPR024665 | |
| Domain | DUF3454 | 2.94e-05 | 3 | 59 | 2 | PF11936 | |
| Domain | DUF3454_notch | 2.94e-05 | 3 | 59 | 2 | IPR024600 | |
| Domain | COMP | 2.94e-05 | 3 | 59 | 2 | PF11598 | |
| Domain | DUF3454 | 2.94e-05 | 3 | 59 | 2 | SM01334 | |
| Domain | FBN | 2.94e-05 | 3 | 59 | 2 | IPR011398 | |
| Domain | Notch | 5.86e-05 | 4 | 59 | 2 | IPR008297 | |
| Domain | NODP | 5.86e-05 | 4 | 59 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 5.86e-05 | 4 | 59 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 5.86e-05 | 4 | 59 | 2 | IPR010660 | |
| Domain | NOD | 5.86e-05 | 4 | 59 | 2 | PF06816 | |
| Domain | NOD | 5.86e-05 | 4 | 59 | 2 | SM01338 | |
| Domain | NODP | 5.86e-05 | 4 | 59 | 2 | SM01339 | |
| Domain | ConA-like_dom | 6.51e-05 | 219 | 59 | 6 | IPR013320 | |
| Domain | IGc2 | 9.61e-05 | 235 | 59 | 6 | SM00408 | |
| Domain | Ig_sub2 | 9.61e-05 | 235 | 59 | 6 | IPR003598 | |
| Domain | TSP_3 | 9.75e-05 | 5 | 59 | 2 | PF02412 | |
| Domain | LNR | 9.75e-05 | 5 | 59 | 2 | PS50258 | |
| Domain | TSP3 | 9.75e-05 | 5 | 59 | 2 | PS51234 | |
| Domain | TSP_CTER | 9.75e-05 | 5 | 59 | 2 | PS51236 | |
| Domain | - | 9.75e-05 | 5 | 59 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 9.75e-05 | 5 | 59 | 2 | IPR008859 | |
| Domain | TSP_C | 9.75e-05 | 5 | 59 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 9.75e-05 | 5 | 59 | 2 | IPR017897 | |
| Domain | Thrombospondin_3-like_rpt | 9.75e-05 | 5 | 59 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 9.75e-05 | 5 | 59 | 2 | IPR028974 | |
| Domain | TB | 2.04e-04 | 7 | 59 | 2 | PF00683 | |
| Domain | Notch_dom | 2.04e-04 | 7 | 59 | 2 | IPR000800 | |
| Domain | Notch | 2.04e-04 | 7 | 59 | 2 | PF00066 | |
| Domain | NL | 2.04e-04 | 7 | 59 | 2 | SM00004 | |
| Domain | - | 2.52e-04 | 39 | 59 | 3 | 2.120.10.30 | |
| Domain | - | 2.71e-04 | 8 | 59 | 2 | 3.90.290.10 | |
| Domain | Ig_I-set | 3.32e-04 | 190 | 59 | 5 | IPR013098 | |
| Domain | I-set | 3.32e-04 | 190 | 59 | 5 | PF07679 | |
| Domain | TB | 3.48e-04 | 9 | 59 | 2 | PS51364 | |
| Domain | TB_dom | 3.48e-04 | 9 | 59 | 2 | IPR017878 | |
| Domain | 6-blade_b-propeller_TolB-like | 4.13e-04 | 46 | 59 | 3 | IPR011042 | |
| Domain | CUB | 4.98e-04 | 49 | 59 | 3 | PF00431 | |
| Domain | CUB | 5.28e-04 | 50 | 59 | 3 | SM00042 | |
| Domain | - | 5.30e-04 | 11 | 59 | 2 | 2.40.155.10 | |
| Domain | GFP-like | 5.30e-04 | 11 | 59 | 2 | IPR023413 | |
| Domain | - | 5.93e-04 | 52 | 59 | 3 | 2.60.120.290 | |
| Domain | CUB | 6.27e-04 | 53 | 59 | 3 | PS01180 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.30e-07 | 84 | 47 | 6 | M7098 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.79e-06 | 30 | 47 | 4 | M27216 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.79e-06 | 30 | 47 | 4 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.79e-06 | 30 | 47 | 4 | MM15812 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 5.63e-06 | 11 | 47 | 3 | M158 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.86e-06 | 300 | 47 | 8 | M610 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 6.62e-06 | 140 | 47 | 6 | M587 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 7.48e-06 | 12 | 47 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 9.70e-06 | 13 | 47 | 3 | M47423 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 1.60e-05 | 46 | 47 | 4 | M239 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 1.90e-05 | 48 | 47 | 4 | M27642 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 1.97e-05 | 100 | 47 | 5 | M27158 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 4.32e-05 | 59 | 47 | 4 | M27218 | |
| Pathway | PID_NOTCH_PATHWAY | 4.32e-05 | 59 | 47 | 4 | M17 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 6.72e-05 | 66 | 47 | 4 | MM15925 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 7.55e-05 | 68 | 47 | 4 | M27303 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 9.61e-05 | 27 | 47 | 3 | M39545 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.08e-04 | 5 | 47 | 2 | M27411 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.09e-04 | 143 | 47 | 5 | M27275 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 1.17e-04 | 76 | 47 | 4 | M27219 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.32e-04 | 30 | 47 | 3 | M27772 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 1.62e-04 | 6 | 47 | 2 | M27068 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.77e-04 | 33 | 47 | 3 | M39503 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 2.26e-04 | 7 | 47 | 2 | M27199 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.39e-04 | 41 | 47 | 3 | M27778 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 4.47e-04 | 45 | 47 | 3 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 4.77e-04 | 46 | 47 | 3 | MM15971 | |
| Pathway | WP_FOCAL_ADHESION | 5.05e-04 | 199 | 47 | 5 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 5.05e-04 | 199 | 47 | 5 | M7253 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 5.08e-04 | 47 | 47 | 3 | M7946 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 5.87e-04 | 11 | 47 | 2 | M47865 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.03e-04 | 12 | 47 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 7.03e-04 | 12 | 47 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 7.03e-04 | 12 | 47 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 8.29e-04 | 13 | 47 | 2 | M47534 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 9.65e-04 | 14 | 47 | 2 | M27808 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.09e-03 | 61 | 47 | 3 | M39540 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 1.11e-03 | 15 | 47 | 2 | M27202 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.27e-03 | 16 | 47 | 2 | M47424 | |
| Pathway | WP_CANCER_PATHWAYS | 1.35e-03 | 507 | 47 | 7 | M48302 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.37e-03 | 66 | 47 | 3 | M18 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.41e-03 | 250 | 47 | 5 | M27554 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 1.43e-03 | 17 | 47 | 2 | M39443 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.43e-03 | 17 | 47 | 2 | M39389 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.61e-03 | 18 | 47 | 2 | M614 | |
| Pathway | WP_NEPHROGENESIS | 1.61e-03 | 18 | 47 | 2 | M40045 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.76e-03 | 72 | 47 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 1.83e-03 | 73 | 47 | 3 | MM15906 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.99e-03 | 20 | 47 | 2 | M27881 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 2.30e-03 | 79 | 47 | 3 | M27643 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.41e-03 | 22 | 47 | 2 | M27210 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 2.56e-03 | 82 | 47 | 3 | M594 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 2.56e-03 | 82 | 47 | 3 | MM15922 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 2.74e-03 | 84 | 47 | 3 | M3228 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 2.87e-03 | 24 | 47 | 2 | M11190 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.11e-03 | 25 | 47 | 2 | M39713 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.21e-03 | 302 | 47 | 5 | M39719 | |
| Pathway | WP_FOCAL_ADHESION | 3.43e-03 | 187 | 47 | 4 | MM15913 | |
| Pathway | REACTOME_VISUAL_PHOTOTRANSDUCTION | 3.54e-03 | 92 | 47 | 3 | MM14881 | |
| Pathway | WP_GASTRIC_CANCER_NETWORK_1 | 3.89e-03 | 28 | 47 | 2 | M39347 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 3.89e-03 | 28 | 47 | 2 | M6177 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 4.00e-03 | 96 | 47 | 3 | M39581 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 4.00e-03 | 96 | 47 | 3 | M39834 | |
| Pathway | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | 4.20e-03 | 198 | 47 | 4 | M18311 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 4.44e-03 | 326 | 47 | 5 | MM15917 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 4.76e-03 | 31 | 47 | 2 | M592 | |
| Pathway | WP_PI3KAKT_SIGNALING | 5.23e-03 | 339 | 47 | 5 | M39736 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 5.38e-03 | 33 | 47 | 2 | M604 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 5.70e-03 | 34 | 47 | 2 | M39390 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HSPG2 LRP12 THBS3 FBN2 PXDN MEGF8 LAMA5 LAMB1 ROBO1 ADGRE5 NAGPA LRP1B LDLR P3H4 NOTCH1 NOTCH2 | 1.33e-10 | 1201 | 60 | 16 | 35696571 |
| Pubmed | 2.12e-09 | 31 | 60 | 5 | 22274697 | ||
| Pubmed | Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. | 4.88e-09 | 3 | 60 | 3 | 14726396 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.08e-08 | 15 | 60 | 4 | 15895400 | |
| Pubmed | 1.62e-08 | 167 | 60 | 7 | 22159717 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 1.95e-08 | 4 | 60 | 3 | 22390640 | |
| Pubmed | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. | 1.95e-08 | 4 | 60 | 3 | 30226866 | |
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 10551863 | ||
| Pubmed | 1.95e-08 | 4 | 60 | 3 | 24398584 | ||
| Pubmed | 2.23e-08 | 175 | 60 | 7 | 28071719 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.28e-08 | 101 | 60 | 6 | 23382219 | |
| Pubmed | 3.04e-08 | 19 | 60 | 4 | 25691540 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 11713346 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 9719032 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 4.87e-08 | 5 | 60 | 3 | 15064243 | |
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 15882997 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 27118257 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 35064244 | ||
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 10958687 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 9.73e-08 | 6 | 60 | 3 | 12244553 | |
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 15226394 | ||
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 22526456 | ||
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 9.73e-08 | 6 | 60 | 3 | 19603167 | |
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 9108364 | ||
| Pubmed | 9.73e-08 | 6 | 60 | 3 | 31071093 | ||
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.16e-07 | 26 | 60 | 4 | 34189436 | |
| Pubmed | 1.54e-07 | 71 | 60 | 5 | 33541421 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 10383933 | ||
| Pubmed | 1.70e-07 | 7 | 60 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 1.70e-07 | 7 | 60 | 3 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 1.70e-07 | 7 | 60 | 3 | 24711412 | |
| Pubmed | 1.84e-07 | 29 | 60 | 4 | 22613833 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 2.63e-07 | 79 | 60 | 5 | 18757743 | |
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 2.72e-07 | 8 | 60 | 3 | 9489770 | |
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 2.72e-07 | 8 | 60 | 3 | 22652674 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 2.72e-07 | 8 | 60 | 3 | 15465493 | |
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 8872465 | ||
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 2.72e-07 | 8 | 60 | 3 | 23529140 | |
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 9858718 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 15068794 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 11044610 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 19914235 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 22156581 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 2.72e-07 | 8 | 60 | 3 | 12242716 | |
| Pubmed | 2.99e-07 | 81 | 60 | 5 | 39217171 | ||
| Pubmed | 4.07e-07 | 164 | 60 | 6 | 32409323 | ||
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 12122015 | ||
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 11118901 | ||
| Pubmed | 4.07e-07 | 9 | 60 | 3 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 5.81e-07 | 10 | 60 | 3 | 23665443 | |
| Pubmed | 5.81e-07 | 10 | 60 | 3 | 11784026 | ||
| Pubmed | 5.81e-07 | 10 | 60 | 3 | 24015274 | ||
| Pubmed | 5.81e-07 | 10 | 60 | 3 | 9034910 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 5.81e-07 | 10 | 60 | 3 | 16100707 | |
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 5.81e-07 | 10 | 60 | 3 | 16554364 | |
| Pubmed | 6.98e-07 | 40 | 60 | 4 | 27068110 | ||
| Pubmed | 6.98e-07 | 40 | 60 | 4 | 23362348 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 7.97e-07 | 11 | 60 | 3 | 23472759 | |
| Pubmed | Defects in somite formation in lunatic fringe-deficient mice. | 7.97e-07 | 11 | 60 | 3 | 9690472 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 7.97e-07 | 11 | 60 | 3 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 7.97e-07 | 11 | 60 | 3 | 15499562 | |
| Pubmed | 7.97e-07 | 11 | 60 | 3 | 10878608 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 7.97e-07 | 11 | 60 | 3 | 21524702 | |
| Pubmed | 7.97e-07 | 11 | 60 | 3 | 12866128 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 15465494 | ||
| Pubmed | Notch signaling promotes nephrogenesis by downregulating Six2. | 1.06e-06 | 12 | 60 | 3 | 27633993 | |
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 32147304 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 14732396 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 9396756 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 17572911 | ||
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 1.38e-06 | 13 | 60 | 3 | 31202705 | |
| Pubmed | Node and midline defects are associated with left-right development in Delta1 mutant embryos. | 1.38e-06 | 13 | 60 | 3 | 12441287 | |
| Pubmed | 1.38e-06 | 13 | 60 | 3 | 12682087 | ||
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 1.38e-06 | 13 | 60 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 1.38e-06 | 13 | 60 | 3 | 20558824 | |
| Pubmed | 1.74e-06 | 50 | 60 | 4 | 23658023 | ||
| Pubmed | 1.75e-06 | 14 | 60 | 3 | 23806616 | ||
| Pubmed | 1.75e-06 | 14 | 60 | 3 | 19783738 | ||
| Pubmed | 1.75e-06 | 14 | 60 | 3 | 14757642 | ||
| Pubmed | 1.94e-06 | 118 | 60 | 5 | 21078624 | ||
| Pubmed | 2.19e-06 | 15 | 60 | 3 | 12971992 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 2.19e-06 | 15 | 60 | 3 | 12921739 | |
| Pubmed | 2.19e-06 | 15 | 60 | 3 | 9264260 | ||
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 2.19e-06 | 15 | 60 | 3 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 2.19e-06 | 15 | 60 | 3 | 16914494 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 GBF1 MEGF6 MEGF8 ADAMTSL5 LAMA5 PAPLN LDLR ST14 NOTCH1 NOTCH2 | 2.61e-06 | 1105 | 60 | 11 | 35748872 |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 2.69e-06 | 16 | 60 | 3 | 12617809 | |
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 17273555 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 2.69e-06 | 16 | 60 | 3 | 27641601 | |
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 17601529 | ||
| Pubmed | Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. | 2.69e-06 | 16 | 60 | 3 | 17229764 | |
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 10842072 | ||
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 20007915 | ||
| Pubmed | Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells. | 2.69e-06 | 16 | 60 | 3 | 19185577 | |
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 32161758 | ||
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 2.93e-06 | 2 | 60 | 2 | 24508387 | |
| Pubmed | Notch controls generation and function of human effector CD8+ T cells. | 2.93e-06 | 2 | 60 | 2 | 23380742 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 21466361 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 20069650 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 15625786 | ||
| Interaction | IGFL3 interactions | 1.78e-14 | 75 | 60 | 10 | int:IGFL3 | |
| Interaction | FBXO2 interactions | SEMA4D HSPG2 FBN2 PXDN MEGF8 JAG1 LRP2 LAMA5 LAMB1 ROBO1 BCHE LAMC2 LRP1B ST14 NOTCH1 NOTCH2 | 4.42e-14 | 411 | 60 | 16 | int:FBXO2 |
| Interaction | NTN5 interactions | 6.95e-11 | 24 | 60 | 6 | int:NTN5 | |
| Interaction | CFC1 interactions | 3.64e-09 | 126 | 60 | 8 | int:CFC1 | |
| Interaction | SLURP1 interactions | 1.04e-08 | 144 | 60 | 8 | int:SLURP1 | |
| Interaction | PRG2 interactions | 1.10e-08 | 285 | 60 | 10 | int:PRG2 | |
| Interaction | ZFP41 interactions | 1.74e-08 | 57 | 60 | 6 | int:ZFP41 | |
| Interaction | EDN3 interactions | 3.19e-08 | 108 | 60 | 7 | int:EDN3 | |
| Interaction | DLK2 interactions | 6.93e-08 | 36 | 60 | 5 | int:DLK2 | |
| Interaction | ZNF408 interactions | 2.42e-07 | 145 | 60 | 7 | int:ZNF408 | |
| Interaction | FOXD4L6 interactions | 3.40e-07 | 49 | 60 | 5 | int:FOXD4L6 | |
| Interaction | FBN1 interactions | 4.17e-07 | 51 | 60 | 5 | int:FBN1 | |
| Interaction | MFAP5 interactions | 4.61e-07 | 52 | 60 | 5 | int:MFAP5 | |
| Interaction | DEFA1 interactions | 5.17e-07 | 100 | 60 | 6 | int:DEFA1 | |
| Interaction | LGALS1 interactions | 5.66e-07 | 332 | 60 | 9 | int:LGALS1 | |
| Interaction | GREM2 interactions | 4.36e-06 | 37 | 60 | 4 | int:GREM2 | |
| Interaction | SDF2L1 interactions | 4.84e-06 | 322 | 60 | 8 | int:SDF2L1 | |
| Interaction | NID2 interactions | 5.71e-06 | 86 | 60 | 5 | int:NID2 | |
| Interaction | SIRPD interactions | 5.71e-06 | 86 | 60 | 5 | int:SIRPD | |
| Interaction | TIMP3 interactions | 7.14e-06 | 90 | 60 | 5 | int:TIMP3 | |
| Interaction | ELSPBP1 interactions | 7.96e-06 | 92 | 60 | 5 | int:ELSPBP1 | |
| Interaction | IGSF5 interactions | 8.92e-06 | 14 | 60 | 3 | int:IGSF5 | |
| Interaction | RNASE4 interactions | 8.92e-06 | 14 | 60 | 3 | int:RNASE4 | |
| Interaction | WNT3A interactions | 1.36e-05 | 49 | 60 | 4 | int:WNT3A | |
| Interaction | PTPRK interactions | 1.42e-05 | 177 | 60 | 6 | int:PTPRK | |
| Interaction | ATN1 interactions | 1.95e-05 | 187 | 60 | 6 | int:ATN1 | |
| Interaction | CCN6 interactions | 2.35e-05 | 19 | 60 | 3 | int:CCN6 | |
| Interaction | USP10 interactions | 2.39e-05 | 290 | 60 | 7 | int:USP10 | |
| Interaction | LYPD1 interactions | 2.67e-05 | 58 | 60 | 4 | int:LYPD1 | |
| Interaction | ZNF224 interactions | 2.76e-05 | 20 | 60 | 3 | int:ZNF224 | |
| Interaction | EGFL6 interactions | 3.21e-05 | 21 | 60 | 3 | int:EGFL6 | |
| Interaction | CACNA1A interactions | 3.26e-05 | 123 | 60 | 5 | int:CACNA1A | |
| Interaction | IL5RA interactions | 3.39e-05 | 124 | 60 | 5 | int:IL5RA | |
| Interaction | ST14 interactions | 3.45e-05 | 207 | 60 | 6 | int:ST14 | |
| Interaction | ZDHHC15 interactions | 3.52e-05 | 125 | 60 | 5 | int:ZDHHC15 | |
| Interaction | FBN2 interactions | 4.20e-05 | 65 | 60 | 4 | int:FBN2 | |
| Interaction | FBLN2 interactions | 4.46e-05 | 66 | 60 | 4 | int:FBLN2 | |
| Interaction | GFI1B interactions | 5.27e-05 | 136 | 60 | 5 | int:GFI1B | |
| Interaction | MFNG interactions | 6.97e-05 | 27 | 60 | 3 | int:MFNG | |
| Interaction | TAFA3 interactions | 8.59e-05 | 78 | 60 | 4 | int:TAFA3 | |
| Interaction | ALG12 interactions | 1.06e-04 | 31 | 60 | 3 | int:ALG12 | |
| Interaction | PI15 interactions | 1.09e-04 | 83 | 60 | 4 | int:PI15 | |
| Interaction | SH2D1B interactions | 1.17e-04 | 32 | 60 | 3 | int:SH2D1B | |
| Interaction | C1orf54 interactions | 1.39e-04 | 167 | 60 | 5 | int:C1orf54 | |
| Interaction | MKRN2 interactions | 1.42e-04 | 385 | 60 | 7 | int:MKRN2 | |
| Interaction | LTBP1 interactions | 1.63e-04 | 92 | 60 | 4 | int:LTBP1 | |
| Interaction | CRISPLD1 interactions | 1.81e-04 | 7 | 60 | 2 | int:CRISPLD1 | |
| Interaction | RFNG interactions | 1.81e-04 | 7 | 60 | 2 | int:RFNG | |
| Interaction | WNT10A interactions | 1.81e-04 | 37 | 60 | 3 | int:WNT10A | |
| Interaction | LDLRAP1 interactions | 1.81e-04 | 37 | 60 | 3 | int:LDLRAP1 | |
| Interaction | IGFBP4 interactions | 2.47e-04 | 41 | 60 | 3 | int:IGFBP4 | |
| Interaction | JAG1 interactions | 2.47e-04 | 41 | 60 | 3 | int:JAG1 | |
| Interaction | NOTCH2 interactions | 2.53e-04 | 423 | 60 | 7 | int:NOTCH2 | |
| Interaction | ASCC3 interactions | 2.79e-04 | 194 | 60 | 5 | int:ASCC3 | |
| Interaction | DAB1 interactions | 2.91e-04 | 107 | 60 | 4 | int:DAB1 | |
| Interaction | JAG2 interactions | 3.24e-04 | 110 | 60 | 4 | int:JAG2 | |
| Interaction | RNASEL interactions | 3.26e-04 | 45 | 60 | 3 | int:RNASEL | |
| Interaction | SH2D1A interactions | 3.26e-04 | 45 | 60 | 3 | int:SH2D1A | |
| Interaction | DNAJB9 interactions | 3.36e-04 | 202 | 60 | 5 | int:DNAJB9 | |
| Interaction | NOTCH3 interactions | 3.59e-04 | 113 | 60 | 4 | int:NOTCH3 | |
| Interaction | RPS27L interactions | 3.68e-04 | 206 | 60 | 5 | int:RPS27L | |
| Interaction | PRG3 interactions | 4.19e-04 | 49 | 60 | 3 | int:PRG3 | |
| Interaction | DKK2 interactions | 4.19e-04 | 49 | 60 | 3 | int:DKK2 | |
| Interaction | CD14 interactions | 5.00e-04 | 52 | 60 | 3 | int:CD14 | |
| Interaction | INSIG1 interactions | 5.58e-04 | 127 | 60 | 4 | int:INSIG1 | |
| Interaction | THBS1 interactions | 5.58e-04 | 127 | 60 | 4 | int:THBS1 | |
| Interaction | ADAMTS15 interactions | 5.64e-04 | 12 | 60 | 2 | int:ADAMTS15 | |
| Interaction | MFAP2 interactions | 5.64e-04 | 12 | 60 | 2 | int:MFAP2 | |
| Interaction | CRKL interactions | 5.72e-04 | 227 | 60 | 5 | int:CRKL | |
| Interaction | FBLN1 interactions | 5.92e-04 | 129 | 60 | 4 | int:FBLN1 | |
| Interaction | POU2AF1 interactions | 6.22e-04 | 56 | 60 | 3 | int:POU2AF1 | |
| Interaction | HOXA1 interactions | 6.53e-04 | 356 | 60 | 6 | int:HOXA1 | |
| Interaction | SCGB1C1 interactions | 6.66e-04 | 13 | 60 | 2 | int:SCGB1C1 | |
| Interaction | SVEP1 interactions | 6.66e-04 | 13 | 60 | 2 | int:SVEP1 | |
| Interaction | GML interactions | 6.89e-04 | 58 | 60 | 3 | int:GML | |
| Interaction | SP1 interactions | 7.44e-04 | 365 | 60 | 6 | int:SP1 | |
| Interaction | AP1M2 interactions | 7.61e-04 | 60 | 60 | 3 | int:AP1M2 | |
| Interaction | LFNG interactions | 7.75e-04 | 14 | 60 | 2 | int:LFNG | |
| Interaction | GGH interactions | 7.78e-04 | 243 | 60 | 5 | int:GGH | |
| Interaction | CD55 interactions | 8.37e-04 | 62 | 60 | 3 | int:CD55 | |
| Interaction | PLAT interactions | 8.77e-04 | 63 | 60 | 3 | int:PLAT | |
| Interaction | HRG interactions | 8.77e-04 | 63 | 60 | 3 | int:HRG | |
| Interaction | SLIT2 interactions | 8.77e-04 | 63 | 60 | 3 | int:SLIT2 | |
| Interaction | SRY interactions | 8.93e-04 | 15 | 60 | 2 | int:SRY | |
| Interaction | COL5A1 interactions | 9.61e-04 | 65 | 60 | 3 | int:COL5A1 | |
| Interaction | CLEC2B interactions | 9.65e-04 | 147 | 60 | 4 | int:CLEC2B | |
| Interaction | MEX3A interactions | 9.68e-04 | 384 | 60 | 6 | int:MEX3A | |
| Interaction | PDGFRA interactions | 9.81e-04 | 385 | 60 | 6 | int:PDGFRA | |
| Interaction | DEFB123 interactions | 1.02e-03 | 16 | 60 | 2 | int:DEFB123 | |
| Interaction | LCN6 interactions | 1.05e-03 | 67 | 60 | 3 | int:LCN6 | |
| Cytoband | 19p13 | 5.77e-04 | 27 | 60 | 2 | 19p13 | |
| Cytoband | 7q22 | 1.15e-03 | 38 | 60 | 2 | 7q22 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 3.87e-03 | 797 | 60 | 5 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3p21 | 8.28e-03 | 316 | 60 | 3 | chr3p21 | |
| GeneFamily | Low density lipoprotein receptors | 1.30e-08 | 13 | 39 | 4 | 634 | |
| GeneFamily | Laminin subunits | 2.01e-06 | 12 | 39 | 3 | 626 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.37e-05 | 161 | 39 | 5 | 593 | |
| GeneFamily | ADAMTS like | 9.46e-05 | 7 | 39 | 2 | 947 | |
| GeneFamily | PHD finger proteins | 1.61e-02 | 90 | 39 | 2 | 88 | |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 THBS3 NTNG2 FBN2 PXDN COMP KCP LAMA5 LAMB1 ESM1 PAPLN LAMC2 SSPOP FBN3 SVEP1 | 3.70e-17 | 275 | 59 | 15 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THBS3 NTNG2 FBN2 PXDN COMP KCP LAMA5 LAMB1 PAPLN LAMC2 SSPOP FBN3 SVEP1 | 4.58e-16 | 196 | 59 | 13 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | HSPG2 THBS3 NTNG2 FBN2 PXDN COMP KCP LAMA5 LAMB1 ESM1 PAPLN LAMC2 SSPOP SVEP1 | 9.50e-16 | 270 | 59 | 14 | MM17057 |
| Coexpression | NABA_MATRISOME | SEMA4D HSPG2 THBS3 NTNG2 FBN2 PXDN COMP MEGF6 MEGF8 ADAMTSL5 WFIKKN1 KCP LAMA5 LAMB1 ESM1 PAPLN LAMC2 SSPOP ST14 FBN3 SVEP1 | 2.88e-15 | 1026 | 59 | 21 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | THBS3 NTNG2 FBN2 PXDN COMP KCP LAMA5 LAMB1 PAPLN LAMC2 SSPOP SVEP1 | 1.31e-14 | 191 | 59 | 12 | MM17059 |
| Coexpression | NABA_MATRISOME | SEMA4D HSPG2 THBS3 NTNG2 FBN2 PXDN COMP MEGF6 MEGF8 ADAMTSL5 WFIKKN1 KCP LAMA5 LAMB1 ESM1 PAPLN LAMC2 SSPOP ST14 SVEP1 | 2.80e-14 | 1008 | 59 | 20 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 3.62e-10 | 40 | 59 | 6 | M5887 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 2.22e-07 | 59 | 59 | 5 | M47989 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 6.02e-07 | 8 | 59 | 3 | M9884 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_UP | 5.73e-06 | 199 | 59 | 6 | M5406 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.94e-06 | 16 | 59 | 3 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 5.94e-06 | 16 | 59 | 3 | M2207 | |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 8.63e-06 | 18 | 59 | 3 | M3506 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.20e-05 | 20 | 59 | 3 | MM17053 | |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 1.20e-05 | 482 | 59 | 8 | M12144 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.86e-05 | 23 | 59 | 3 | M48001 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 3.22e-05 | 80 | 59 | 4 | M15368 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 4.21e-05 | 30 | 59 | 3 | M47990 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 5.13e-05 | 32 | 59 | 3 | M5903 | |
| Coexpression | GSE30962_ACUTE_VS_CHRONIC_LCMV_PRIMARY_INF_CD8_TCELL_UP | 8.82e-05 | 200 | 59 | 5 | M5046 | |
| Coexpression | GSE3720_UNSTIM_VS_LPS_STIM_VD1_GAMMADELTA_TCELL_UP | 8.82e-05 | 200 | 59 | 5 | M6357 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_60H_UP | 8.82e-05 | 200 | 59 | 5 | M9655 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ERBB3 ADAMTSL5 JAG1 LRP2 LAMB1 LAMC2 ADGRE5 ST14 SVEP1 NOTCH1 | 1.29e-04 | 1074 | 59 | 10 | M1941 |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_ONLY_DN | 1.34e-04 | 44 | 59 | 3 | M1316 | |
| Coexpression | GROSS_HYPOXIA_VIA_ELK3_ONLY_DN | 1.34e-04 | 44 | 59 | 3 | MM1128 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 1.37e-04 | 681 | 59 | 8 | M5314 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | 1.71e-04 | 703 | 59 | 8 | MM1055 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 2.26e-04 | 385 | 59 | 6 | M39264 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 2.46e-04 | 135 | 59 | 4 | M5825 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 2.96e-04 | 574 | 59 | 7 | M39056 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 9.42e-08 | 398 | 57 | 10 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | SEMA4D HOXC8 FBN2 JAG1 LRP2 LAMA5 LAMB1 ROBO1 LAMC2 ST14 NOTCH1 NOTCH2 | 8.93e-07 | 783 | 57 | 12 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 5.25e-06 | 165 | 57 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 2.32e-05 | 62 | 57 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 2.79e-05 | 456 | 57 | 8 | GSM777032_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.80e-05 | 65 | 57 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 2.93e-05 | 459 | 57 | 8 | GSM777037_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#2_top-relative-expression-ranked_500 | 4.81e-05 | 148 | 57 | 5 | gudmap_kidney_P3_CapMes_Crym_k2_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_500 | 5.76e-05 | 370 | 57 | 7 | gudmap_kidney_P3_CapMes_Crym_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | HSPG2 DENND4A PXDN JAG1 LAMB1 ESM1 ROBO1 ADGRE5 NOTCH1 STAB1 | 7.54e-05 | 846 | 57 | 10 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | HSPG2 DENND4A PXDN JAG1 LAMB1 ESM1 ROBO1 ADGRE5 NOTCH1 STAB1 | 7.61e-05 | 847 | 57 | 10 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 8.29e-05 | 166 | 57 | 5 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_200 | 1.06e-04 | 175 | 57 | 5 | gudmap_kidney_P4_CapMesRenVes_Crym_200 | |
| CoexpressionAtlas | kidney_e15.5_SmlBldVes_Tie2_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.18e-04 | 287 | 57 | 6 | gudmap_kidney_e15.5_SmlBldVes_Tie2_k4_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_DevVasOvary_Flk_top-relative-expression-ranked_500 | 1.18e-04 | 415 | 57 | 7 | gudmap_dev gonad_e12.5_F_gudmap_devVasOvary_Flk_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.67e-04 | 439 | 57 | 7 | GSM777059_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_k-means-cluster#1_top-relative-expression-ranked_500 | 2.85e-04 | 118 | 57 | 4 | gudmap_developingLowerUrinaryTract_e15.5_Urothelium_500_k1 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | LRP12 THBS3 GBF1 FBN2 PXDN MEGF6 WFIKKN1 JAG1 LRP2 LAMB1 FBN3 NOTCH2 | 4.32e-04 | 1466 | 57 | 12 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.52e-07 | 182 | 59 | 6 | d3a037268f026eb2f84428b1821022503cef7756 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-07 | 184 | 59 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-07 | 184 | 59 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-07 | 184 | 59 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.78e-07 | 187 | 59 | 6 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.84e-07 | 188 | 59 | 6 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | Differ-Basal|World / shred by cell class for mouse tongue | 2.22e-07 | 194 | 59 | 6 | 851eff82c9f3d44c86e3e127a804bbd1fced6a7c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-07 | 197 | 59 | 6 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-07 | 197 | 59 | 6 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-07 | 197 | 59 | 6 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-07 | 197 | 59 | 6 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 160 | 59 | 5 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-06 | 160 | 59 | 5 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-06 | 169 | 59 | 5 | 0425d2580ed325178f522c0093ff4623de6ce7a8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-06 | 169 | 59 | 5 | fec669968a77060bd77ee8695034e35a642c984f | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.08e-06 | 170 | 59 | 5 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 3.17e-06 | 171 | 59 | 5 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.55e-06 | 175 | 59 | 5 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_3|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 3.75e-06 | 177 | 59 | 5 | 3d955ea938a1d2fb1b6d68d4997fd454bd632dfc | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 4.19e-06 | 181 | 59 | 5 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.30e-06 | 182 | 59 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 4.53e-06 | 184 | 59 | 5 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.53e-06 | 184 | 59 | 5 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 185 | 59 | 5 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 185 | 59 | 5 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-06 | 185 | 59 | 5 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.66e-06 | 185 | 59 | 5 | 0b5a0df58ae2ad8261f40f152775747af4f3937a | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.91e-06 | 187 | 59 | 5 | 4ae7465174e0295d2c3b614b321a3b2f514dd22a | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.91e-06 | 187 | 59 | 5 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.17e-06 | 189 | 59 | 5 | 5d9da836ce4308b8458bb3be3871a0aca734b6cd | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating3_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.58e-06 | 192 | 59 | 5 | d3634574b2e8d2ded6446969361b70761b331aea | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 5.72e-06 | 193 | 59 | 5 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.87e-06 | 194 | 59 | 5 | c5e77650d7abee339ec38fa78a622bb124db3fa5 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.87e-06 | 194 | 59 | 5 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 6.01e-06 | 195 | 59 | 5 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-06 | 195 | 59 | 5 | df644b4c3ddccd34614ece5a2378000e6bc0fa10 | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_II_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 6.01e-06 | 195 | 59 | 5 | 0e3aac1b1a1fd483f5fb9a394eb90c0e1ce63542 | |
| ToppCell | facs-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.01e-06 | 195 | 59 | 5 | c4648c0332c3826776f9ad3f5f803dbac2b4c0c0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.17e-06 | 196 | 59 | 5 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.17e-06 | 196 | 59 | 5 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | droplet-Heart-nan-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.17e-06 | 196 | 59 | 5 | e386526332138e636aef2542c11316347a45689c | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.32e-06 | 197 | 59 | 5 | ea746772adb9df4ddb0508d4ef35f2027bf09c35 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Epithelial|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-06 | 197 | 59 | 5 | b1c6a15bf6c0645952a7247182dc71baf4736869 | |
| ToppCell | ASK452-Epithelial-Transformed_epithelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 6.32e-06 | 197 | 59 | 5 | b22a79a5922c865a360e2afc5506a08a512fa76a | |
| ToppCell | AT1-AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 6.48e-06 | 198 | 59 | 5 | a5b3617ea2ed4bffba59edcf6284799c2b3bbb29 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.64e-06 | 199 | 59 | 5 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | 501a3b93624df463458a35d3e6648d4ccc941724 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-CHRM2-L1-3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.80e-06 | 200 | 59 | 5 | d1f36a8232411933b1494168ec912fd0e5246428 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-06 | 200 | 59 | 5 | 105564ee05bd11685b5747ee32d5350cf3c2e2e1 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 6.80e-06 | 200 | 59 | 5 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.80e-06 | 200 | 59 | 5 | ac8a5d71acd4d401995babd233f0d3738e8ad2a5 | |
| ToppCell | facs-Brain_Myeloid-Cortex-3m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.06e-05 | 153 | 59 | 4 | 0ef7c45cdd854c79e527006034029767f8e108b2 | |
| ToppCell | remission-unassigned|remission / disease stage, cell group and cell class | 5.19e-05 | 154 | 59 | 4 | 4130769829b838cc8a075c87ff6c187f0f507f8b | |
| ToppCell | remission-unassigned|World / disease stage, cell group and cell class | 5.32e-05 | 155 | 59 | 4 | d81bec894381e3e2d6249a567e8108b8423e5c54 | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Treg_cell_3|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 5.59e-05 | 157 | 59 | 4 | 6a0aa66964eecbbc232abf1d2e6c8422e4ce69d0 | |
| ToppCell | AT1-AT2_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 5.73e-05 | 158 | 59 | 4 | 3bc51cfd37b289cc3e866b54ce55a298e5eff690 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 158 | 59 | 4 | e7db0ee4740e3c7a4d97d7cd7462e2c2ab458a4b | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.73e-05 | 158 | 59 | 4 | d39e020c3e77eb9d3de600a171d22f94357061d4 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.73e-05 | 158 | 59 | 4 | d78e7e52657dc094430291fec07e9c298be9e584 | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.02e-05 | 160 | 59 | 4 | 58ed3a074932ccc951e07868dfdc61b99ae1cc2b | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-05 | 164 | 59 | 4 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 168 | 59 | 4 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 168 | 59 | 4 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.44e-05 | 169 | 59 | 4 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | PND01-03-samps-Endothelial-Postnatal_endothelial-endothelial_cells_D|PND01-03-samps / Age Group, Lineage, Cell class and subclass | 8.33e-05 | 174 | 59 | 4 | b4f3f5334803e5903bc496decf923f2e44f7fa3c | |
| ToppCell | wk_15-18-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.33e-05 | 174 | 59 | 4 | 2cd6638b361ca05ab83d09ce657194aed97873b7 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-05 | 174 | 59 | 4 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.33e-05 | 174 | 59 | 4 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.33e-05 | 174 | 59 | 4 | 4da79da7a09ee1e345102c5331675ebcdbe56171 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-05 | 176 | 59 | 4 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-05 | 176 | 59 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 8.71e-05 | 176 | 59 | 4 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-05 | 176 | 59 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 8.71e-05 | 176 | 59 | 4 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 8.90e-05 | 177 | 59 | 4 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l25-31|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 8.90e-05 | 177 | 59 | 4 | 6b4fe717928814dafcd13090b1c90ea973938c6d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_ZNF322P1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.10e-05 | 178 | 59 | 4 | 2a36475c260088f69f3b8c282d910e5eaa5c5c2d | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-05 | 178 | 59 | 4 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.10e-05 | 178 | 59 | 4 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | droplet-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.70e-05 | 181 | 59 | 4 | 2c44c41b4e8a75ebdbaeb0c6cc5a03f17c44758c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.70e-05 | 181 | 59 | 4 | d7e04e0ca549eac6d9b1192b6578f9b54943d54f | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.70e-05 | 181 | 59 | 4 | b116c68393d8836bac080f81a8fcbeb52e0403e7 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.01e-04 | 183 | 59 | 4 | 6f8f997ffc9eaebca2683de125b6069d07c07d26 | |
| ToppCell | Basal|World / shred by cell class for mouse tongue | 1.01e-04 | 183 | 59 | 4 | c6729a207526ff4aa48176207b9353176f631fea | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 183 | 59 | 4 | 5cfcd589a480e67654d3d94e71916f122150db10 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 183 | 59 | 4 | c3ea8d3b916ffcaca3156e0d77a952724554c4ab | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 183 | 59 | 4 | 81003ddc24164959dd41bb12fcac72638789b8f2 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-04 | 183 | 59 | 4 | 8a799807fbf24456a9811e0c64068187940a2f71 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 183 | 59 | 4 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | 61caaa31975e05c9a6512079c791fed5a9e2d39f | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.03e-04 | 184 | 59 | 4 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | 03da0f0f89f1ca5a3ccca1e22972f3129464e68e | |
| ToppCell | facs-Trachea-24m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 184 | 59 | 4 | 9ed2a65a4ca0ebbbb89ace61027522f93369843d | |
| ToppCell | normal_Lung-Endothelial_cells-Tumor_ECs|normal_Lung / Location, Cell class and cell subclass | 1.03e-04 | 184 | 59 | 4 | 7ee98acda030366ac6cf3890a6d93fd0426712ed | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-04 | 185 | 59 | 4 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | facs-Trachea-nan-24m-Epithelial-mucus_secreting_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 185 | 59 | 4 | e502ec54971f518d0cf1b619b745607a8ab5ddf3 | |
| ToppCell | (0)_MSCs|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.08e-04 | 186 | 59 | 4 | a832c1e0035bcd559722eccf262c145deb3494c7 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.08e-04 | 186 | 59 | 4 | 96f6603cc75fa1ffc2a2fdb94ec0ec09498e540a | |
| ToppCell | facs-Lung-EPCAM-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-04 | 186 | 59 | 4 | 7c4eb769574f9f32753cea1cc38c711dabba88b9 | |
| ToppCell | (0)_MSCs-(00)_Lepr-MSC|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.08e-04 | 186 | 59 | 4 | f0d156167d7cc2cd8a76e5a364233e9f2170bc01 | |
| Computational | Adhesion molecules. | 1.65e-04 | 141 | 40 | 5 | MODULE_122 | |
| Computational | Placenta genes. | 2.54e-04 | 463 | 40 | 8 | MODULE_38 | |
| Drug | BM165 | 1.42e-08 | 11 | 60 | 4 | CID003352881 | |
| Drug | Rgd Peptide | 2.10e-07 | 239 | 60 | 8 | CID000104802 | |
| Drug | AC1L9INI | 4.81e-07 | 59 | 60 | 5 | CID000445839 | |
| Drug | sulfate | HSPG2 ERBB3 THBS3 COMP ADAMTSL5 NDUFAF3 LAMA5 LAMB1 BCHE LAMC2 METAP2 LDLR AR ST14 CCS | 8.91e-07 | 1292 | 60 | 15 | CID000001117 |
| Drug | monatepil | 9.85e-07 | 29 | 60 | 4 | CID000060810 | |
| Drug | LMWH | HSPG2 LRP12 ERBB3 THBS3 ADAMTSL5 LRP2 LAMA5 LAMB1 LAMC2 LDLR AR | 1.10e-06 | 663 | 60 | 11 | CID000000772 |
| Drug | AC1L1G72 | 2.83e-06 | 11 | 60 | 3 | CID000003553 | |
| Drug | 1,2-dimethylhydrazine | 3.17e-06 | 86 | 60 | 5 | CID000001322 | |
| Drug | AC1L1C2F | 1.06e-05 | 110 | 60 | 5 | CID000001711 | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 1.11e-05 | 191 | 60 | 6 | 6498_UP | |
| Drug | chondroitin sulfate | 1.23e-05 | 413 | 60 | 8 | CID000024766 | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 1.32e-05 | 197 | 60 | 6 | 3382_UP | |
| Drug | kalinin | 1.34e-05 | 55 | 60 | 4 | CID000032518 | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.36e-05 | 198 | 60 | 6 | 2809_DN | |
| Drug | Suloctidil [54063-56-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.40e-05 | 199 | 60 | 6 | 6675_DN | |
| Drug | Artemisinin [63968-64-9]; Up 200; 14.2uM; HL60; HG-U133A | 1.44e-05 | 200 | 60 | 6 | 1714_UP | |
| Drug | CC270 | 1.78e-05 | 59 | 60 | 4 | CID006918852 | |
| Drug | LG 5 | 1.90e-05 | 60 | 60 | 4 | CID011840957 | |
| Drug | AIS C | 2.05e-05 | 3 | 60 | 2 | CID003082878 | |
| Drug | ALT-711 | 2.24e-05 | 21 | 60 | 3 | CID000216304 | |
| Drug | enzacamene | 2.30e-05 | 129 | 60 | 5 | ctd:C038939 | |
| Drug | dermatan sulfate | 2.46e-05 | 220 | 60 | 6 | CID000032756 | |
| Drug | G 3012 | 2.57e-05 | 132 | 60 | 5 | CID000120739 | |
| Drug | Sikvav | 3.39e-05 | 24 | 60 | 3 | CID005487517 | |
| Drug | AC1L1EPA | 4.08e-05 | 4 | 60 | 2 | CID000028140 | |
| Drug | AR 12465 | 4.08e-05 | 4 | 60 | 2 | CID000127645 | |
| Drug | 2-amino-5-methylpyridine | 5.11e-05 | 77 | 60 | 4 | CID000015348 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 5.54e-05 | 155 | 60 | 5 | 6817_DN | |
| Drug | butylparaben | 5.88e-05 | 157 | 60 | 5 | ctd:C038091 | |
| Drug | AC1L1B58 | 6.05e-05 | 29 | 60 | 3 | CID000001288 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; HL60; HT_HG-U133A | 6.44e-05 | 160 | 60 | 5 | 6133_DN | |
| Drug | 25-hydroxycholesterol | 6.44e-05 | 160 | 60 | 5 | CID000065094 | |
| Drug | AC1O0B8G | 6.52e-05 | 262 | 60 | 6 | CID000091605 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 6.63e-05 | 161 | 60 | 5 | 3556_DN | |
| Drug | hyaluronan | 6.66e-05 | 263 | 60 | 6 | CID000024759 | |
| Drug | NSC 714187 | 7.52e-05 | 85 | 60 | 4 | CID005288693 | |
| Drug | Mifepristone | 9.70e-05 | 553 | 60 | 8 | ctd:D015735 | |
| Drug | Leucomyosuppressin | 1.02e-04 | 6 | 60 | 2 | CID000176039 | |
| Drug | Tnrnflrfamide | 1.02e-04 | 6 | 60 | 2 | CID003081636 | |
| Drug | Uranium | 1.27e-04 | 296 | 60 | 6 | ctd:D014501 | |
| Drug | Calcort | 1.37e-04 | 38 | 60 | 3 | CID000026709 | |
| Drug | Ikvav | 1.37e-04 | 38 | 60 | 3 | CID000131343 | |
| Drug | silver-sulfide (Ag2S | 1.42e-04 | 7 | 60 | 2 | CID000030686 | |
| Drug | caramiphen | 1.42e-04 | 7 | 60 | 2 | CID000006472 | |
| Drug | NSC70156 | 1.42e-04 | 7 | 60 | 2 | CID000117947 | |
| Drug | AC1L9FMG | 1.42e-04 | 7 | 60 | 2 | CID000444053 | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.56e-04 | 193 | 60 | 5 | 4676_UP | |
| Drug | MRK 003 | 1.58e-04 | 760 | 60 | 9 | ctd:C523799 | |
| Drug | Tiletamine hydrochloride; Down 200; 15.4uM; MCF7; HT_HG-U133A | 1.59e-04 | 194 | 60 | 5 | 6516_DN | |
| Drug | 15d-PGJ2; Down 200; 10uM; MCF7; HT_HG-U133A | 1.63e-04 | 195 | 60 | 5 | 5591_DN | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Down 200; 6.6uM; PC3; HT_HG-U133A | 1.63e-04 | 195 | 60 | 5 | 6648_DN | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 1.63e-04 | 195 | 60 | 5 | 2875_UP | |
| Drug | Ethotoin [86-35-1]; Down 200; 19.6uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 4366_DN | |
| Drug | Amphotericin B [1397-89-3]; Up 200; 4.4uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 5404_UP | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Down 200; 11.8uM; PC3; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 6286_DN | |
| Drug | Phthalylsulfathiazole [85-73-4]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 5249_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 6673_DN | |
| Drug | Tranexamic acid [1197-18-8]; Down 200; 25.4uM; MCF7; HT_HG-U133A | 1.67e-04 | 196 | 60 | 5 | 6238_DN | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 6773_DN | |
| Drug | Picotamide monohydrate [80530-63-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 1.71e-04 | 197 | 60 | 5 | 6787_DN | |
| Drug | Gabexate mesilate [56974-61-9]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 4804_UP | |
| Drug | Sulfisoxazole [127-69-5]; Up 200; 15uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 3218_UP | |
| Drug | LY 294002; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA | 1.75e-04 | 198 | 60 | 5 | 996_DN | |
| Drug | Trimethobenzamide hydrochloride [554-92-7]; Down 200; 9.4uM; HL60; HG-U133A | 1.75e-04 | 198 | 60 | 5 | 2002_DN | |
| Drug | Disulfiram [97-77-8]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 5729_DN | |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 5220_UP | |
| Drug | Amprolium hydrochloride [137-88-2]; Down 200; 12.6uM; MCF7; HT_HG-U133A | 1.75e-04 | 198 | 60 | 5 | 1479_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; PC3; HT_HG-U133A | 1.79e-04 | 199 | 60 | 5 | 5832_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; HL60; HT_HG-U133A | 1.84e-04 | 200 | 60 | 5 | 2348_UP | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 1.84e-04 | 200 | 60 | 5 | 6293_DN | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 1.84e-04 | 200 | 60 | 5 | 6450_UP | |
| Drug | tolclofos-methyl | 1.89e-04 | 8 | 60 | 2 | CID000091664 | |
| Drug | AC1L1S7V | 1.89e-04 | 8 | 60 | 2 | CID000009054 | |
| Drug | PPI-2458 | 1.89e-04 | 8 | 60 | 2 | CID006918653 | |
| Drug | quinaprilat | 1.99e-04 | 43 | 60 | 3 | CID000107994 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 2.13e-04 | 44 | 60 | 3 | ctd:C419410 | |
| Drug | B-Ms | 2.34e-04 | 114 | 60 | 4 | CID000445091 | |
| Drug | pitavastatin | 2.34e-04 | 114 | 60 | 4 | CID005282451 | |
| Drug | 9-phenanthrol | 2.43e-04 | 9 | 60 | 2 | ctd:C091375 | |
| Drug | pyrachlostrobin | 2.56e-04 | 811 | 60 | 9 | ctd:C513428 | |
| Drug | Urokinase | 3.03e-04 | 10 | 60 | 2 | DB00013 | |
| Drug | 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine | 3.03e-04 | 10 | 60 | 2 | ctd:C028145 | |
| Drug | isosorbide | 3.03e-04 | 10 | 60 | 2 | CID000012597 | |
| Drug | Indans | 3.03e-04 | 10 | 60 | 2 | ctd:D007189 | |
| Drug | AC1L1GUQ | 3.12e-04 | 50 | 60 | 3 | CID000003849 | |
| Drug | 1-hydroxypyrene | 3.31e-04 | 51 | 60 | 3 | ctd:C033146 | |
| Drug | bicalutamide | 3.33e-04 | 125 | 60 | 4 | CID000002375 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 3.22e-06 | 15 | 58 | 3 | C0496930 | |
| Disease | Benign neoplasm of bladder | 3.22e-06 | 15 | 58 | 3 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 3.22e-06 | 15 | 58 | 3 | C0154091 | |
| Disease | Hepatic ductular hypoplasia | 3.80e-06 | 2 | 58 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 3.80e-06 | 2 | 58 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 3.80e-06 | 2 | 58 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 3.80e-06 | 2 | 58 | 2 | C1956125 | |
| Disease | Alagille Syndrome | 3.80e-06 | 2 | 58 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 3.80e-06 | 2 | 58 | 2 | cv:C0085280 | |
| Disease | Carcinoma of bladder | 5.76e-06 | 18 | 58 | 3 | C0699885 | |
| Disease | connective tissue disease (implicated_via_orthology) | 1.14e-05 | 3 | 58 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Cerebral Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0750936 | |
| Disease | Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 1.61e-05 | 25 | 58 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 1.61e-05 | 25 | 58 | 3 | C0338070 | |
| Disease | Glioblastoma | 1.81e-05 | 79 | 58 | 4 | C0017636 | |
| Disease | Gemistocytic astrocytoma | 1.81e-05 | 26 | 58 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 1.81e-05 | 26 | 58 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 1.81e-05 | 26 | 58 | 3 | C0334582 | |
| Disease | Anaplastic astrocytoma | 2.04e-05 | 27 | 58 | 3 | C0334579 | |
| Disease | Giant Cell Glioblastoma | 2.31e-05 | 84 | 58 | 4 | C0334588 | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.43e-05 | 32 | 58 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | neurogenic locus notch homolog protein 1 measurement | 3.78e-05 | 5 | 58 | 2 | EFO_0008246 | |
| Disease | pack-years measurement, systolic blood pressure | 4.13e-05 | 34 | 58 | 3 | EFO_0006335, EFO_0006526 | |
| Disease | cortical surface area measurement | SEMA4D ERBB3 FBN2 ZAN MEGF6 PRRC2C JAG1 ROBO1 METAP2 FBN3 SVEP1 | 5.36e-05 | 1345 | 58 | 11 | EFO_0010736 |
| Disease | ductal carcinoma in situ (is_marker_for) | 6.26e-05 | 39 | 58 | 3 | DOID:0060074 (is_marker_for) | |
| Disease | Glioblastoma Multiforme | 6.88e-05 | 111 | 58 | 4 | C1621958 | |
| Disease | adenocarcinoma (implicated_via_orthology) | 7.92e-05 | 7 | 58 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | central nervous system cancer (implicated_via_orthology) | 7.92e-05 | 7 | 58 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | brain measurement, neuroimaging measurement | 9.94e-05 | 550 | 58 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.57e-04 | 53 | 58 | 3 | C4707243 | |
| Disease | cystic kidney disease (implicated_via_orthology) | 1.69e-04 | 10 | 58 | 2 | DOID:2975 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of skin | 2.17e-04 | 59 | 58 | 3 | C0007114 | |
| Disease | Skin Neoplasms | 2.17e-04 | 59 | 58 | 3 | C0037286 | |
| Disease | Malignant neoplasm of breast | 2.32e-04 | 1074 | 58 | 9 | C0006142 | |
| Disease | anorexia nervosa | 3.59e-04 | 70 | 58 | 3 | MONDO_0005351 | |
| Disease | serum amyloid A-1 protein measurement | 5.69e-04 | 18 | 58 | 2 | EFO_0008282 | |
| Disease | Mammary Carcinoma, Human | 5.70e-04 | 525 | 58 | 6 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 5.70e-04 | 525 | 58 | 6 | C1257931 | |
| Disease | Mammary Neoplasms | 5.82e-04 | 527 | 58 | 6 | C1458155 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 6.36e-04 | 19 | 58 | 2 | DOID:2256 (is_implicated_in) | |
| Disease | sodium-coupled monocarboxylate transporter 1 measurement | 6.36e-04 | 19 | 58 | 2 | EFO_0802076 | |
| Disease | Breast Carcinoma | 6.48e-04 | 538 | 58 | 6 | C0678222 | |
| Disease | congenital heart disease (is_implicated_in) | 1.02e-03 | 24 | 58 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Carcinoma, Pancreatic Ductal | 1.02e-03 | 24 | 58 | 2 | C0887833 | |
| Disease | brain cancer (implicated_via_orthology) | 1.20e-03 | 26 | 58 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | memory performance | 1.25e-03 | 409 | 58 | 5 | EFO_0004874 | |
| Disease | Dupuytren Contracture | 1.27e-03 | 108 | 58 | 3 | EFO_0004229 | |
| Disease | Prostatic Neoplasms | 1.30e-03 | 616 | 58 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.30e-03 | 616 | 58 | 6 | C0376358 | |
| Disease | cortical thickness | 1.44e-03 | 1113 | 58 | 8 | EFO_0004840 | |
| Disease | pneumonia, COVID-19 | 1.45e-03 | 113 | 58 | 3 | EFO_0003106, MONDO_0100096 | |
| Disease | ocular sarcoidosis | 1.56e-03 | 116 | 58 | 3 | EFO_0010723 | |
| Disease | colorectal cancer (implicated_via_orthology) | 1.59e-03 | 30 | 58 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | Lung Neoplasms | 1.84e-03 | 265 | 58 | 4 | C0024121 | |
| Disease | Malignant neoplasm of lung | 1.87e-03 | 266 | 58 | 4 | C0242379 | |
| Disease | blood urea nitrogen measurement | 1.94e-03 | 452 | 58 | 5 | EFO_0004741 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGPQDTDCFACRHFN | 236 | P21860 | |
| DQCQACFNSSPDLAD | 266 | Q6ZN18 | |
| NSCCQNIDQSFPGFH | 91 | P06276 | |
| YSNNSPCNEANHCCI | 121 | Q8WW27 | |
| NGSHCTDVNECNAHP | 121 | P49747 | |
| SGQNPCHSSTHCLNN | 166 | P48960 | |
| FQCSCHAGFQSTPDR | 1136 | Q75N90 | |
| SGEGCTDDNECHAQP | 2246 | Q75N90 | |
| SGNHPQSNSEDAFKC | 141 | Q68CQ1 | |
| ADDSNLNTTCPFCGN | 1471 | Q7Z401 | |
| NCDPQGSVSSQCDAA | 1276 | P98160 | |
| DECASNPCQHGATCS | 1151 | Q04721 | |
| HFEDSNDCPRCGNQV | 46 | Q86SE9 | |
| ENNTPDCTESSCFNG | 981 | P46531 | |
| QNHCPNGSDEKNCFF | 436 | Q9Y561 | |
| EDSVNCFNHSCPDDQ | 876 | Q9NZR2 | |
| EIHSPAGCNGNEFQC | 1046 | Q9NZR2 | |
| TAGCAPNNTCDENAF | 2796 | Q9NZR2 | |
| NNCAAHYTPNAGDTT | 226 | P50579 | |
| GQHFDPNTNLPDSCC | 11 | Q9UKP3 | |
| DLPDQCCGSHGNEDN | 491 | Q9UPZ3 | |
| QCNGHADTCNEQDGT | 2381 | Q7Z7M0 | |
| FPSCQPCQCNGHADD | 861 | P07942 | |
| CNAAHSFGPSCNEFT | 1086 | P07942 | |
| LCNAHQNCPDGSDED | 3571 | P98164 | |
| VCAGHDNNQPDSFAA | 686 | P10275 | |
| NSANECQSCNCYGHA | 351 | O15230 | |
| APNQCDLNCLAEGHA | 131 | Q6ZMM2 | |
| CDPNNLCHSGRTFDA | 381 | P15170 | |
| SCHAFHPEENAQDCG | 1096 | Q7Z3S7 | |
| DLTNNCNSCGNHFNP | 136 | O14618 | |
| CNSCGNHFNPDGASH | 141 | O14618 | |
| GYQQNPCSLSCHGDA | 71 | P31273 | |
| SNNYAVDCPQHCDSS | 21 | Q9NQ30 | |
| NCNGSPFANSDACFS | 811 | Q92538 | |
| NCEHGAFSCPACYNQ | 601 | Q13753 | |
| NTEGSFQCDCPLGHE | 1176 | P35556 | |
| DQHSAAPGFTCNTCS | 131 | A4D161 | |
| CDNAHGDANQPARDS | 1311 | Q96T23 | |
| QNTNDCSPHPCYNSG | 781 | P78504 | |
| QACACFNGASCDPVH | 1001 | O75095 | |
| HENPYLCSNECDASN | 71 | Q96CW9 | |
| EGPHNSDNCEACLQG | 146 | Q9BQQ7 | |
| PGSQHQDACNNCSCQ | 4131 | A2VEC9 | |
| DQVCDNSQCGQPFHQ | 321 | Q9NW38 | |
| NGQNFTDADSPCHAC | 496 | Q6ZWJ8 | |
| NGTLASYPSDHCQDN | 296 | Q9UK23 | |
| HTDANNQSACFEAPD | 886 | Q9Y520 | |
| CGTNAFQPACDHLNL | 126 | Q92854 | |
| ECFFNPCHNSGTCQQ | 1196 | Q4LDE5 | |
| TPNACATFNFLCHEG | 146 | Q9BU61 | |
| GCHGNANNFASEQEC | 786 | O95428 | |
| DSEAFCHANCSGPAP | 71 | Q92791 | |
| DNSDEQGCSCPAQTF | 516 | Q9Y5Y6 | |
| FSDGQHCSNVCSNDP | 841 | Q92626 | |
| HFECNQCGETFNRPS | 206 | A6NDX5 | |
| PNANCVQDSAGASTC | 1426 | Q9NY15 | |
| PNTGNNHNDCSISCC | 981 | Q9Y6N7 | |
| DTDSFGDACDNCPNV | 531 | P49746 | |
| LNGHQDSCASNSNEC | 201 | P21506 | |
| GNNFHSRESCEDACP | 396 | Q96NZ8 | |
| VNSCHQGTPAFACSQ | 1276 | P52746 | |
| NDGEPEAACNASNTH | 276 | Q9UL17 | |
| CNPGFLFSDNHCIQA | 1076 | Q9Y493 | |
| NECLDNNGGCSHVCN | 316 | P01130 |